Viatris Aktie

8,81 EUR -0,24 EUR -2,65 %

22:43:34

BMN

10,18 USD -0,27 USD -2,59 %

21:59:57

BTT

Viatris jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.10,71 Mrd. EUR

Div. Rendite3,86%

WKNA2QAME

ISINUS92556V1061

SymbolVTRS

Viatris Aktien News

Sortieren:Datum Meistgelesen

03.07.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Viatris, Inc. of Class Action Lawsuit and Upcoming Deadline - VTRS

01.07.23PR NewswireROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important July 14 Deadline in Securities Class Action - VTRS

30.06.23PR NewswireVTRS SHAREHOLDER ALERT: Jakubowitz Law Reminds Viatris Shareholders of a Lead Plaintiff Deadline of July 14, 2023

29.06.23PR NewswireVTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

28.06.23PR NewswireViatris to Report Second Quarter 2023 Financial Results on August 7, 2023

20.06.23PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

17.06.23PR NewswirePomerantz Law Firm Announces the Filing of a Class Action Against Viatris, Inc. and Certain Officers - VTRS

09.06.23PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

06.06.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS

01.06.23PR NewswireVIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Vi...

30.05.23PR NewswireKESSLER TOPAZ MELTZER & CHECK, LLP ANNOUNCES A SECURITIES FRAUD CLASS ACTION FILED AGAINST VIATRIS INC. (VTRS)

30.05.23PR NewswireViatris Named to USA Today's Inaugural List of America's Climate Leaders 2023

22.05.23PR NewswireInvestor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Viatris Inc. (VTRS) Investors of Class Action and to Actively Participate

22.05.23PR NewswireRobert J. Coury to Transition from Executive Chairman of Viatris to Chairman Emeritus and Senior Strategic Advisor to the Board and Management at the End of the Year

22.05.23PR NewswireViatris Announces Appointment of Leo Groothuis to Company's Board of Directors

19.05.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS

18.05.23PR NewswireROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS

17.05.23PR NewswireViatris to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

16.05.23PR NewswireViatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine

16.05.23PR NewswireVTRS NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Viatris Inc.

09.05.23PR NewswireVTRS NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Viatris Inc.

09.05.23MyDividendsViatris hält die Dividende stabil

08.05.23PR NewswireViatris Reports Strong Financial and Operational Results for First Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]

08.05.23PR NewswireVTRS ALERT: The Law Offices of Vincent Wong Investigate Viatris Inc. for Potential Violations of Securities Laws

05.05.23PR NewswireVTRS FRAUD ALERT: Jakubowitz Law is Investigating Viatris Inc. in Connection with Potential Violations of Federal Securities Laws

24.04.23PR NewswireViatris and Mapi Pharma to Highlight Latest Results of Multiple Sclerosis Research at American Academy of Neurology 75th Annual Meeting

20.04.23PR NewswireViatris auf der LinkedIn-Liste der Top-Unternehmen in Irland für 2023 aufgeführt

19.04.23PR NewswireViatris Named in 2023 LinkedIn Top Companies List in Ireland

12.04.23PR NewswireViatris to Report First Quarter 2023 Financial Results on May 8, 2023

06.04.23PR NewswireNCD Academy Launches New Health Equity and Social Determinants of Health Course

27.02.23PR NewswireViatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023

27.02.23PR NewswireViatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

15.02.23PR NewswireViatris to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023

17.01.23PR NewswireViatris recognised as a Top Employer 2023 in the UK

03.01.23PR NewswireViatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division

29.12.22PR NewswireViatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors

23.12.22PR NewswireViatris Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference

19.12.22PR Newswire'NCDs in Focus Act Now' Summit organized by Viatris

14.12.22PR NewswireViatris Announces Donations Totaling $1 Million to Provide Aid Supporting Access to Healthcare, Food Security and Water Stewardship

14.12.22PR NewswireViatris Announces Approval of Emissions Reduction Targets by the Science Based Target initiative (SBTi)

Viatris News

Viatris News: auf dieser Seite finden Sie alle Viatris News und Nachrichten zur Viatris Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Viatris News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Viatris News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.